1. There is no Covid emergency for children under five years old.
Children have a 99.997% recovery rate and a body of medical literature indicates that almost zero healthy children under five years old have died from Covid.
• A large study conducted in Germany showed zero deaths for children under 5 and a case fatality rate of three out of a million in children without comorbidities.
•A Johns Hopkins study monitoring 48,000 children diagnosed with Covid showed a zero mortality rate in children under 18 without comorbidities.
•A study in Nature demonstrated that children under 18 with no comorbidities have virtually no risk of death.
2. The data in connection with the Moderna and Pfizer EUA applications in kids is abysmal
• The Pfizer clinical trial in kids 6 months to four years old failed in December 2021 and failed again in February 2022. Adding a third dose did not solve the underlying problems with this shot in this age group.
• Against the Omicron variant, after one month, the Pfizer shot was only 12% effective in kids 5 to 11, after 6 weeks vaccine effectiveness was a shocking MINUS 41% (vaccinated kids were significantly more likely to catch Covid than the unvaccinated). Recommending a vaccine with negative efficacy is insanity.
• Finland, Sweden, Denmark, and Norway have all suspended the use of the Moderna shot in young people because it leads to myocarditis. The FDA risk benefit assessment cited 26 studies showing that mRNA shots in general, and Moderna in particular, increase the risk of myocarditis.
3. The harms from mRNA shots in children are catastrophic.
There are now 49,283 VAERS reports of adverse events in children following Covid shots including 114 reports of death, 457 reports of permanent disability, and 1,326 reports of myocarditis. These reports likely understate harms by a factor of 41 to 100.
You have a professional and moral obligation to reject the Moderna and Pfizer EUA applications to inject mRNA into little kids. (From the Autism Action Network newsletter)
Click here to send emails to the members of the ACIP and other key decision-makers and to view talking points and contact info for the people who will be involved with the ACIP meeting on Friday 16 and Saturday 17 June.
